Scholar Rock Holding (SRRK) Times Interest Earned (2017 - 2026)
Scholar Rock Holding's (SRRK) quarterly Times Interest Earned came in at -$43.08 in Q1 2026, down 14.62% year-on-year from -$50.46 in Q1 2025, and up 47.78% quarter-over-quarter from -$82.49 in Q4 2025.
Scholar Rock Holding (SRRK) Times Interest Earned (2017 - 2026) Analysis & Trends
Scholar Rock Holding's Times Interest Earned history runs 10 years deep, the most recent figure standing at -$43.08 for Q1 2026.
- On a quarterly basis, Times Interest Earned fell 14.62% year-over-year to -$43.08 in Q1 2026; TTM through Mar 2026 was -$48.8, a 49.59% decrease from a year earlier, with the FY2025 full-year figure at -$2.07, down 141.06% from the prior year.
- Times Interest Earned rose to -$43.08 in Q1 2026 per SRRK's latest filing, from -$82.49 in the prior quarter.
- Across five years, Times Interest Earned topped out at -$0.65 in Q3 2025 and bottomed at -$82.49 in Q4 2025.
- The 5-year median for Times Interest Earned is -$21.83 (2024), against an average of -$25.89.
- Across the five-year window, Times Interest Earned sank 8814.95% in 2022 and surged 97.03% in 2025, its largest moves.
- Year by year, Times Interest Earned stood at -$30.17 in 2022, then advanced by 3.86% to -$29.0 in 2023, then gained by 16.39% to -$24.25 in 2024, then sank by 240.16% to -$82.49 in 2025, then jumped by 47.78% to -$43.08 in 2026.
- Per Business Quant, the three latest SRRK Times Interest Earned figures stand at -$43.08 (Q1 2026), -$82.49 (Q4 2025), and -$0.65 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Scholar Rock Holding | 6.30 Bn | 6.30 Bn | - | -43.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.08 |
| Dec 31, 2025 | -82.49 |
| Sep 30, 2025 | -0.65 |
| Jun 30, 2025 | -0.72 |
| Mar 31, 2025 | -37.59 |
| Dec 31, 2024 | -24.25 |
| Sep 30, 2024 | -21.83 |
| Jun 30, 2024 | -16.86 |
| Mar 31, 2024 | -33.73 |
| Dec 31, 2023 | -29.00 |
| Sep 30, 2023 | -18.75 |
| Jun 30, 2023 | -13.01 |
| Mar 31, 2023 | -10.34 |
| Dec 31, 2022 | -30.17 |
| Sep 30, 2022 | -16.93 |
| Jun 30, 2022 | -57.68 |
| Mar 31, 2022 | -3.06 |
| Dec 31, 2021 | -60.14 |
| Sep 30, 2021 | -0.73 |
| Jun 30, 2021 | -0.65 |